This announcement is a separate document:
迈普医学：监事会关于公司2024年限制性股票激励计划首次授予部分激励对象名单的核查意见及公示情况说明
Medprin Regenerative Medical Technologies: The Supervisory Board's verification opinion and public announcement on the initial grant list of the restricted stock incentive plan for the company in 2024.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.